メタ情報
| meta description平均長 | 108.64 |
|---|
| OGPありページ数 | 0 |
|---|
| Twitterカードありページ数 | 0 |
|---|
内部リンク分析（Internal）
| ユニーク内部リンク数 | 221 |
|---|
| ページあたり内部リンク平均 | 68.6 |
|---|
内部リンク 深さヒストグラム
| キー | 値 |
|---|
| 0 | 239 |
| 1 | 2805 |
| 2 | 589 |
| 3 | 1768 |
| 4 | 19 |
| 5 | 38 |
| 6 | 30 |
キーワード分析（KeywordMap）
ワードクラウド上位
| 語 | 重み |
|---|
| utm | 1 |
| October | 0.905859 |
| 平均スコア | 0.79589 |
| Health | 0.739957 |
| CAR | 0.716301 |
| Drug | 0.687615 |
| November | 0.589384 |
| dose | 0.589384 |
| Pharmacy | 0.56077 |
| supply | 0.557123 |
| Pharmaceutical | 0.521967 |
| Service | 0.513852 |
| drug | 0.48 |
| email | 0.4474 |
| National | 0.44 |
| また | 0.438493 |
| STAT | 0.421609 |
| FDA | 0.410117 |
| University | 0.400458 |
| Food | 0.4 |
| Administration | 0.4 |
| DDD | 0.397945 |
| Lancet | 0.392923 |
| www | 0.388279 |
| Clinical | 0.388225 |
| new | 0.374763 |
| https | 0.37331 |
| Review | 0.345089 |
| Council | 0.343428 |
| biosimilar | 0.343428 |
| オープンアクセス | 0.338849 |
| DOI | 0.327436 |
| Medicine | 0.327436 |
| England | 0.327436 |
| アフリベルセプト | 0.327436 |
| use | 0.327436 |
| 2mg | 0.327436 |
| REMS | 0.318356 |
| aflibercept | 0.318356 |
| TID | 0.318356 |
| action | 0.318356 |
| plan | 0.318356 |
| year | 0.318356 |
| notification | 0.318356 |
| Source | 0.318356 |
| Community | 0.318356 |
| Oct | 0.313984 |
| fda | 0.308311 |
| Economic | 0.308311 |
| 坂巻コメント | 0.298267 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| https | www | 3.804818 | 88 |
| Administration | Drug | 2.806398 | 41 |
| campaign | utm | 2.775487 | 34 |
| Drug | Food | 2.753074 | 40 |
| email | medium | 2.721702 | 24 |
| Administration | Food | 2.709829 | 30 |
| action | plan | 2.628748 | 16 |
| email | hsenc | 2.597945 | 20 |
| microgram | per | 2.570204 | 13 |
| Community | Source | 2.562957 | 15 |
| hsenc | p2ANqtz | 2.50782 | 16 |
| Administration | FDA | 2.507297 | 28 |
| Pharmacy | Service | 2.505785 | 29 |
| aflibercept | use | 2.486689 | 16 |
| 2mg | aflibercept | 2.486689 | 16 |
| DDD | TID | 2.486689 | 16 |
| medium | utm | 2.457685 | 29 |
| 100mg | 200mg | 2.427686 | 12 |
| 200mg | tablets | 2.427686 | 12 |
| dry | powder | 2.427686 | 12 |
| Favored | Most | 2.366251 | 12 |
| Favored | Nation | 2.366251 | 12 |
| Innovative | Licensing | 2.366251 | 12 |
| File | Refuse | 2.366251 | 12 |
| gene | therapies | 2.366251 | 12 |
| free | sugar | 2.366251 | 12 |
| Online | ahead | 2.360237 | 13 |
| notification | supply | 2.312517 | 16 |
| 2mg | biosimilar | 2.276804 | 16 |
| ICER | Review | 2.243396 | 16 |
| com | statnews | 2.243396 | 16 |
| Access | Licensing | 2.238167 | 12 |
| Access | Pathway | 2.238167 | 12 |
| TID | 四分位範囲 | 2.238167 | 12 |
| cell | gene | 2.238167 | 12 |
| antimicrobial | resistance | 2.238167 | 12 |
| national | resistance | 2.238167 | 12 |
| dose | per | 2.231905 | 13 |
| ahead | print | 2.223688 | 10 |
| been | have | 2.221328 | 11 |
| plan | year | 2.205278 | 12 |
| nhs | sps | 2.195732 | 12 |
| Evaluation | Mitigation | 2.138818 | 12 |
| 100mg | tablets | 2.126389 | 10 |
| dgcid | raven | 2.117714 | 8 |
| hsenc | medium | 2.113068 | 15 |
| action | national | 2.110083 | 12 |
| dose | microgram | 2.103455 | 12 |
| Food | 米国食品医薬品局 | 2.102632 | 16 |
| Council | Pharmaceutical | 2.082933 | 20 |
被リンク情報
このデータの閲覧には会員登録が必要になります。会員登録